Effective treatment of recalcitrant Hailey-Hailey disease with dupilumab

Effective treatment of recalcitrant Hailey-Hailey disease with dupilumab

Saved in:

Bibliographic Details
Main Authors:	Deep Patel, BS, Jason Rosenberg, MD, Jacob Cohen, BS, Kristen E. Holland, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	JAAD Case Reports
Subjects:	benign chronic pemphigus clinical case report dupilumab genetic skin disorder Hailey-Hailey disease inflammatory skin disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512624004363
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recalcitrant Hailey-Hailey disease treated with isotretinoin: A family case series
by: Mahesh Mathur, MD, DCP, et al.
Published: (2025-02-01)

Annular Hailey–Hailey disease
by: Ariane Fizazi, et al.
Published: (2024-12-01)

Efficacy of adalimumab for Hailey-Hailey disease demonstrated by reduction of the Pemphigus Disease Area Index
by: Madeleine Stark, MChD, et al.
Published: (2025-02-01)

Hailey-Hailey disease successfully treated with naloxone: 2 case reports and Review of the literature on efficacy of opioid receptor antagonist in Hailey-Hailey disease patients
by: Junyou Zheng, et al.
Published: (2025-12-01)

Koebnerization of Hailey–Hailey disease into chronic prurigo nodularis: Clearance of both entities under a naloxone therapy
by: Felix Witte, et al.
Published: (2024-12-01)

Papular Acantholytic Dyskeratosis of the Vulva: A Case Report and Literature Review
by: Sakpuwadol N, et al.
Published: (2025-01-01)

Recalcitrant Hailey–Hailey Disease With Satisfactory Response to Apremilast
by: M. Mansilla-Polo, et al.
Published: (2024-11-01)

Pediatric pemphigus herpetiformis treated with rituximab
by: Mira Hamed, MD, et al.
Published: (2024-12-01)

The impact of signaling pathways on the desmosome ultrastructure in pemphigus
by: Thomas Schmitt, et al.
Published: (2025-01-01)

The assessment of dupilumab in children with moderate-to-severe asthma and comorbid type 2 inflammatory diseases
by: Tingting Shi, et al.
Published: (2024-12-01)

Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study
by: Mohamad Reza Kavyani, et al.
Published: (2025-01-01)

Biologic drugs induced vitiligo: case reports and review of literature
by: Xinyi Shao, et al.
Published: (2024-12-01)

Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis
by: C. Grote, et al.
Published: (2025-12-01)

Case report: Dupilumab-induced linear psoriasis: a rare presentation
by: Wen Sun, et al.
Published: (2025-01-01)

[Artículo traducido] Enfermedad de Hailey-Hailey recalcitrante con respuesta satisfactoria a apremilast
by: M. Mansilla-Polo, et al.
Published: (2024-11-01)

Successful treatment of the dupilumab-induced psoriatic dermatitis/arthritis and atopic dermatitis with a JAK inhibitor: A case report and literature review
by: Misuzu Tsunoda, MD, et al.
Published: (2024-11-01)

Inhibitory effect of apigenin on AK23-induced desmoglein3 depletion in HaCaT cell model of pemphigus vulgaris via suppression of p38 MAPK phosphorylation
by: Ji-Eun Lee, et al.
Published: (2024-11-01)

The epidemiology of inflammatory skin disease in older adults
by: Danielle West, BS, et al.
Published: (2025-02-01)

Macrophages in inflammatory skin diseases and skin tumors
by: Si-Han Liu, et al.
Published: (2024-12-01)

Racial and ethnic disparities in dupilumab for pediatric atopic dermatitis in Florida
by: Urdur Jonsdottir, MD, et al.
Published: (2024-11-01)

Incidental Cutaneous Reaction Patterns: Epidermolytic Hyperkeratosis, Acantholytic Dyskeratosis, and Hailey-Hailey-Like Acantholysis: A Potential Marker of Premalignant Skin Change
by: Erich M. Gaertner
Published: (2011-01-01)

Tumors in the setting of dupilumab use: A review of the literature
by: Shumeng Guo, et al.
Published: (2025-01-01)

Granulomatous hyperinflammatory state induced by dupilumab treatment for eosinophilic esophagitis
by: Kanak V. Kennedy, MD, et al.
Published: (2024-11-01)

Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
by: Daiki Nakashima, MD, et al.
Published: (2025-05-01)

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01)

Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study
by: Mohammed Hasosah, et al.
Published: (2025-02-01)

Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma
by: Tomohito Takeshige, et al.
Published: (2024-12-01)

Dermatoxicology /
Published: (1987)

Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review
by: Fabrizio Martora, et al.
Published: (2024-12-01)

Effectiveness of rituximab in the treatment of patients with pemphigus vulgarus
by: Arfenya E. Karamova, et al.
Published: (2024-11-01)

Association Between Scalp Microbiota Imbalance, Disease Severity, and Systemic Inflammatory Markers in Alopecia Areata
by: Pedro J. Gómez-Arias, et al.
Published: (2024-10-01)

A pediatric case of dupilumab-induced pustular psoriasis
by: Nan Dang, et al.
Published: (2024-12-01)

Dupilumab‐Induced Erythrodermic Psoriasiform Dermatitis in Chronic Actinic Dermatitis: Case Report and Innovative Treatment Approach
by: Joe Khodeir, et al.
Published: (2024-11-01)

Dupilumab-induced serum sickness-like reaction in a pediatric patient
by: S. Minhaj Rahman, BA, et al.
Published: (2025-02-01)

Review of modern techniques and analysis of patient outcomes with benign familial pemphigus Gougereau–Haley–Haley
by: Marianna B. Drozhdina, et al.
Published: (2024-12-01)

Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery
by: Sofia Brito, et al.
Published: (2024-10-01)

Improvement of acute phase symptoms of pemphigus foliaceus with spesolimab
by: Shohei Iida, MD, PhD, et al.
Published: (2025-01-01)

Drug Repurposing Using Molecular Network Analysis Identifies Jak as Targetable Driver in Necrobiosis Lipoidica
by: Alysia N. Hughes, et al.
Published: (2024-11-01)

Skin image analysis for detection and quantitative assessment of dermatitis, vitiligo and alopecia areata lesions: a systematic literature review
by: Athanasios Kallipolitis, et al.
Published: (2025-01-01)

Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma
by: Maura C. Gillis, BA, et al.
Published: (2025-02-01)